Xanthine oxidase inhibition for hyperuricemic heart failure patients: design and rationale of the EXACT-HF study.
Michael M. Givertz, Douglas L. Mann, Kerry L. Lee, Jenny C. Ibarra, Eric J. Velazquez, Adrian Rationale of the EXACT-HF Study Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients: Design and Print ISSN: 1941-3289. Online ISSN: 1941-3297 Copyright © 2013 American Heart Association, Inc. All rights reserved. 75231 is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX Circulation: Heart Failure doi: 10.1161/CIRCHEARTFAILURE.113.000394 2013;6:862-868 Circ Heart Fail. http://circheartfailure.ahajournals.org/content/6/4/862 World Wide Web at: The online version of this article, along with updated information and services, is located on the